(Q36461096)

14 August 2017

1 reference

title

The ligand/RAGE axis: lighting the fuse and igniting vascular stress (English)

1 reference

14 August 2017

Barry I Hudson

1 reference

14 August 2017

Kevan Herold

1 reference

14 August 2017

Ann Marie Schmidt

1 reference

14 August 2017

Shi Fang Yan

1 reference

14 August 2017

Yoshifumi Naka

series ordinal

1 reference

14 August 2017

Shi Du Yan

series ordinal

1 reference

14 August 2017

Ravichandran Ramasamy

series ordinal

1 reference

14 August 2017

publication date

1 May 2006

1 reference

Current Atherosclerosis Reports

14 August 2017

published in

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

232-239

1 reference

Malondialdehyde, a lipoperoxidation-derived aldehyde, can bring about secondary oxidative damage to proteins.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

Neurotoxicity of advanced glycation end-products for cultured cortical neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-006-0078-9

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

21 January 2018

1 reference

12 December 2020

Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases

1 reference

12 December 2020

Study of the -429 T/C and -374 T/A receptor for advanced glycation end products promoter polymorphisms in diabetic and nondiabetic subjects with macrovascular disease

1 reference

12 December 2020

Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men.

1 reference

12 December 2020

RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response

1 reference

12 December 2020

Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis

1 reference

12 December 2020

RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB

1 reference

12 December 2020

beta(2)-Microglobulin modified with advanced glycation end products delays monocyte apoptosis

1 reference

12 December 2020

The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients

1 reference

12 December 2020

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

12 December 2020

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications

1 reference

12 December 2020

RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.

1 reference

12 December 2020

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE.

1 reference

12 December 2020

The cellular and molecular basis of peripheral nerve regeneration

1 reference

12 December 2020

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

1 reference

12 December 2020

Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein

1 reference

12 December 2020

The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.

1 reference

12 December 2020

Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury

1 reference

12 December 2020

Intracellular and extracellular roles of S100 proteins

1 reference

12 December 2020

Effects of AGEs on oxidation stress and antioxidation abilities in cultured astrocytes

1 reference

12 December 2020

Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity

1 reference

12 December 2020

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

1 reference

12 December 2020

At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products

1 reference

12 December 2020

RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways

1 reference

12 December 2020

Antagonism of RAGE suppresses peripheral nerve regeneration

1 reference

12 December 2020

Exogenous High-Mobility Group Box 1 Protein Induces Myocardial Regeneration After Infarction via Enhanced Cardiac C-Kit+ Cell Proliferation and Differentiation

1 reference

12 December 2020

RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes

1 reference

12 December 2020

1 reference

12 December 2020

-374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis

1 reference

12 December 2020

The -429 T/C and -374 T/A gene polymorphisms of the receptor of advanced glycation end products gene (RAGE) are not risk factors for coronary artery disease in Slovene population with type 2 diabetes

1 reference

12 December 2020

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

12 December 2020

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

12 December 2020

Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease.

1 reference

12 December 2020

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

12 December 2020

Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response

1 reference

12 December 2020

Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products

1 reference

12 December 2020

HMG-1 as a late mediator of endotoxin lethality in mice

1 reference

12 December 2020

Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system

1 reference

12 December 2020

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

1 reference

12 December 2020

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

12 December 2020

Central role of RAGE-dependent neointimal expansion in arterial restenosis

1 reference

12 December 2020

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

1 reference

12 December 2020

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts

1 reference

12 December 2020

10.1007/S11883-006-0078-9

Identifiers

DOI

1 reference

14 August 2017

1 reference